Dr Reddys Laboratories Share Price Today - Live Blog for August 26, 2025

The stock of Dr Reddys Laboratories Ltd suffered a -0.19% drop, and it's now trading at ₹1,260.00 per share. Investors are assessing whether this decline represents a buying opportunity or a sign of ongoing challenges.

Dr Reddys Laboratories Ltd's share price has fallen by -0.12%, presenting both challenges and opportunities for investors. As of now, it's trading at ₹1,262.30, and market participants are assessing the implications. The stock has a PE ratio of 18.8700, an ROE of 16.8559% and a debt to equity ratio of 0.1394.

Dr Reddys Laboratories Ltd share price surged by 0.12%. With its current market price standing at ₹1,264.00 per share, this stock is garnering increased attention from the investment community.

With a -0.20% decrease, Dr Reddys Laboratories Ltd's share price is now ₹1,261.85. Investors should examine the factors driving this decline. The stock's PE ratio is 18.8700, whereas the industry PE ratio stands at 35.1628.

Dr Reddys Laboratories Ltd experienced a -0.08% downturn in its share price, and it's currently trading at ₹1,263.15. This situation is generating interest among value investors who are evaluating the stock's potential.

Dr Reddys Laboratories Ltd witnessed a -0.08% drop in its share price and is currently trading at ₹1,263.15. With the stock's PE at 18.8700 and the industry PE at 35.1628, investors are weighing their options.

Dr Reddys Laboratories Ltd shares experienced a -0.15% reduction, with the current market price at ₹1,264.05. Investors are carefully considering their positions and seeking insights into the stock's future performance.

Dr Reddys Laboratories Ltd's share price has fallen by -0.02%, a situation worth noting. At present, the stock is trading at ₹1,264.85. Investors might find this a moment to reassess their positions. The stock's current Price-to-Earnings (PE) ratio stands at 18.8700, while the industry PE ratio is 35.1628.

Dr Reddys Laboratories Ltd experienced a -0.02% dip in its share price and is currently trading at ₹1,264.85. The stock has a PE ratio of 18.8700, an ROE of 16.8559% and a debt to equity ratio of 0.1394.

The stock of Dr Reddys Laboratories Ltd is making significant strides, boasting a 0.00% increase and currently trading at ₹1,265.05 per share. This upward trajectory is turning heads in the market.

There was no change in the share price of Dr Reddys Laboratories Ltd, and it continues to trade at ₹1,265.00. The stock has a PE ratio of 18.8700, an ROE of 16.8559%, and a debt to equity ratio of 0.1394.

Dr Reddys Laboratories Ltd experienced a -0.08% dip in its share price and is currently trading at ₹1,263.45. The stock has a PE ratio of 18.8700, an ROE of 16.8559% and a debt to equity ratio of 0.1394.

Dr Reddys Laboratories Ltd experienced a -0.08% downturn in its share price, and it's currently trading at ₹1,263.45. This situation is generating interest among value investors who are evaluating the stock's potential.

Dr Reddys Laboratories Ltd witnessed a notable 0.03% surge in its share price and is presently trading at ₹1,263.20, captivating the attention of market participants.

Demonstrating a commendable 0.02% gain, Dr Reddys Laboratories Ltd's share price is currently situated at ₹1,262.70. In terms of valuation, the stock maintains a PE ratio of 18.8700, while the industry PE ratio stands at 35.1628.

With a -0.17% decrease, Dr Reddys Laboratories Ltd's share price is now at ₹1,262.85. The stock is currently trading at a PE of 18.8700, while the industry PE is 35.1628, prompting investors to assess its value proposition.

Dr Reddys Laboratories Ltd's stock has risen by a substantial 0.22%, and as of now, it's trading at ₹1,265.20 per share. This upward trajectory is attracting keen interest from investors.

Dr Reddys Laboratories Ltd observed a -0.32% decrease in its share price, a situation that merits attention. As of now, it's actively trading at ₹1,262.00. The stock has a PE ratio of 18.8700, an ROE of 16.8559% and a debt to equity ratio of 0.1394.

Dr Reddys Laboratories Ltd observed a remarkable 0.33% surge in its share price and is presently trading at ₹1,266.95. The increased investor interest is driving this surge.

Dr Reddys Laboratories Ltd's stock price surged by 0.01%, reaching the current market value of ₹1,262.75 per share. This surge is a testament to the stock's recent performance.

In recent times, Dr Reddys Laboratories Ltd witnessed a decline of -0.12% in its share price, and it currently trades at ₹1,262.65 per share. The stock has an ROE of 16.8559% and debt to equity ratio of 0.1394.

The stock of Dr Reddys Laboratories Ltd suffered a -0.13% decline, and it currently trades at ₹1,263.45 per share. Investors are closely monitoring this situation, looking for potential signs of recovery.

Dr Reddys Laboratories Ltd's stock has risen by a substantial 0.07%, and as of now, it's trading at ₹1,264.75 per share. This upward trajectory is attracting keen interest from investors.

Increased investor interest has propelled Dr Reddys Laboratories Ltd's stock to a significant 0.17% gain, with the share price now at ₹1,263.65. Notably, the stock's PE ratio stands at 18.8700, and its Return on Equity (ROE) is 16.8559%.

The stock of Dr Reddys Laboratories Ltd suffered a -0.52% decline, and it currently trades at ₹1,260.95 per share. Investors are closely monitoring this situation, looking for potential signs of recovery.

The share price of Dr Reddys Laboratories Ltd has plummeted by -1.74%, signalling a challenging period. Currently trading at ₹1,267.50, this stock has caught the eye of bargain hunters, who may be considering their entry points.